0 Beneficiaries

---

Leg ulceration is one of the chronic complications of sickle cell disorder occurring in one ankle or both. They are often painful, difficult to treat, and impair leading normal lives.
The incidence of leg ulceration among people living with sickle cell anaemia in West Africa is 6-7%.
Leg ulcers mostly affect people between 15-35 years. Leg ulcer treatment service is available at the Centre and affected persons can avail themselves of the treatment regime which has been tried and found to heal the ulcer faster. At Sickle Cell Foundation Nigeria, over 61,000 persons have benefited from the free Leg Ulcer Dressing and drug administration programme.

With Your Support, we can do more!

0 Persons

---

About 1 in 10 children between the ages of 2-16 years living with Sickle Cell anemia have a high risk of developing strokes (Overt or Silent).
These debilitating complications can impede mobility and/or impair intellectual ability.
Happily, strokes can be prevented, if children at risk of developing them can be identified and given treatments At SCFN we have implemented a stroke prevention intervention through our Stroke Prevention Unit using Transcranial Doppler (TCD) Scan machines to identify and prevent strokes in children with SCD.

Since 2011 till date, the Foundation has provided over 30,060+ transcranial Doppler scans for children living with sickle cell disorder. Children aged 2-10 years are most vulnerable but all children aged from 2-16 years are invited to have TCD scans once a year at the national sickle cell centre.


We look forward to partners like you who would sponsor our extension of this health and life-saving service across the country and to subsidise this service to the barest minimum.

0 Reference

---

We run a state-of-the-art Haemoglobin, Chemistry as well as DNA Molecular Laboratory services - Genotype determination, FBC, Hb Quantification, Liver Function Test (LFT), prenatal diagnosis among other haemoglobin, chemistry and molecular investigations.

Over 244,470 haemoglobin and chemistry investigations have been carried out in the laboratory since inception. These advanced facilities reflect SCFN’s commitment to providing accurate and comprehensive diagnostic support for individuals affected by sickle cell disorder (SCD).

The reference Haemoglobin Laboratory at the National Sickle Cell Centre offers world-standard accurate diagnosis thus eliminating the current high risk of obtaining incorrect Hb genotype results, the laboratory results can be emailed to requesting doctors and clinics.

0 Beneficiaries

0 Persons

0 Surgeries

0 Persons

---

Bone Marrow Transplantation is the medically known cure for sickle cell disorder and we offer this service at Sickle Cell Foundation Nigeria.
The Bone Marrow Transplant programme is a joint effort of the Sickle Cell Foundation Nigeria and the Lagos University Teaching Hospital.
Before this cure programme started in-country, the Foundation in Partnership with IME FOUNDATION-Mediterranean Institute of Heamatology Sponsored the bone marrow transplant of 50 persons.

0 Persons

---

We provide prenatal diagnosis services to determine the genotype of unborn children. This advanced genetic testing method empowers expecting parents to determine the genotype of their unborn child during early Our state-of-the-art DNA laboratory provides prenatal diagnosis of fetal genotype services as well as other advanced molecular diagnosis.

This advanced diagnosis provides couples-at-risk (when both parents carry the S or C trait e.g. Hb AS and Hb AS) of sickle cell offspring with the accurate information about their unborn genotype, allaying their anxieties and preparing them for timely interventions such as genetic counselling and appropriate early care, which go a long way to prevent/reduce the frequency of illness or premature death. Since the commencement of this service at the foundation, over 2750 individuals have benefitted from this initiative.

0 Persons

---

We Offer life-saving automated exchange blood transfusion using an APHERESIS MACHINE. An increasing number of patients with serious complications of SCD have begun to access this life-saving service at our national sickle cell centre.
With the Apheresis Machine, the transfusion procedure hardly lasts for up to one hour.
The Exchange Blood Transfusion procedure helps to improve vital oxygen delivery around the body, improving the clinical condition of the patient more efficiently than a simple transfusion. It is done by simultaneously replacing abnormal Red Blood Cells (RBCs) in the patient with normal Donor Red Blood Cells (Hb AA cells).

EBT also helps to prevent or decrease Iron overload associated with simple top-up blood transfusions. The automated system takes out the patient’s red blood cells and returns the patient’s own plasma in addition to the Hb AA Donor red cells, so as to reduce the number of defective Hb SS Red Blood Cells while also controlling fluid balance. EBT is able to reduce Hb SS red cells to about 30 percent from the usual 85/90 percent.